| Literature DB >> 35309139 |
Qingge Guo1,2, Ya Li1,2, Jiarui Li3, Ya You1,2, Changgeng Liu1,2, Kang Chen1,2, Shuyin Li1,2, Bo Lei1,2,3.
Abstract
Purpose: X-linked juvenile retinoschisis (XLRS), caused by mutations in the RS1 gene, is an X-linked recessive inherited disease that typically involves both eyes in the first 2 decades of life. Recently, the phenotype heterogeneity of this condition has drawn increasing attention. We reported various phenotypes caused by RS1 gene mutations in eleven patients from ten Chinese families.Entities:
Keywords: AO; ERG; SS-OCT; X-linked juvenile retinoschisis; next-generation sequencing
Year: 2022 PMID: 35309139 PMCID: PMC8931683 DOI: 10.3389/fgene.2022.832814
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
FIGURE 1Pedigrees of the XLRS families. ■: male patients; □: normal males; ○: normal females; central dot ○: female asymptomatic carriers; ↑: probands; oblique line □: deceased male; and oblique line ○: deceased female.
Genotypes and clinical characteristics of XLRS patients.
| Patient no. | Family no. | Age | Mutation | Exon | States | ACMG score | rs ID | PolyPhen-2 | SIFT | Mutation Taster | Novel/reported | BCVA (OD/OS) | Foveal Retinoschisis (OD/OS) | Peripheral Retinoschisis (OD/OS) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 1, III-1 | 4 | c.208G > C ( | 4 | Hemi | LP (PM2_Supporting + PP3+PM5+PP1+PS4) | rs62645894 | Probably_damaging | Damaging | Disease_causing | Reported | 0.2/0.2 | +/+ | -/- |
| 2 | 2, III-1 | 4 | c.598C > T ( | 6 | Hemi | P (PM2_Supporting + PP3+ PS4) | rs281865357 | Probably_damaging | Damaging | Disease_causing | Reported | 0.2/0.2 | +/+ | -/- |
| 3 | 3, II-3 | 6 | c.626G > A ( | 6 | Hemi | LP (PM2_Supporting + PP3+PM1+PS4) | rs281865362 | Probably_damaging | Tolerable | Disease_causing | Reported | 0.15/0.2 | +/+ | -/- |
| 4 | 4, II-1 | 6 | c.577C > T ( | 6 | Hemi | LP (PM2_Supporting + PP3+PM1+PS4) | rs281865351 | Probably_damaging | Damaging | Disease_causing | Reported | 0.5/0.3 | +/+ | +/+ |
| 5 | 5, II-1 | 57 | c.98G > A ( | 3 | Hemi | P (PVS1+PM2_Supporting + PP3) | None | None | None | Disease_causing_automatic | Reported | 0.04/0.03 | A/A | +/+ |
| 6 | 6, II-2 | 60 | c.657C > A ( | 6 | Hemi | P (PVS1+PM2_Supporting + PP3) | None | None | None | Disease_causing | Novel | 0.06/0.08 | A/A | A/A |
| 7 | 7, III-1 | 18 | c.578C > T ( | 6 | Hemi | LP (PM2_Supporting + PP3+PM1+PS4) | rs281865352 | Probably_damaging | Damaging | Disease_causing | Reported | 0.05/0.3 | +/+ | +/+ |
| 8 | 7, II-3 | 39 | c.578C > T ( | 6 | Hemi | LP (PM2_Supporting + PP3+PM1+PS4) | rs281865352 | Probably_damaging | Damaging | Disease_causing | Reported | 0.4/FC | +/+ | +/+ |
| 9 | 8, II-1 | 7 | c.305G > A ( | 4 | Hemi | P (PM2_Supporting + PP3 +PS4) | rs61752068 | Probably_damaging | Damaging | Disease_causing_automatic | Reported | 1.0/0.2 | -/- | -/+ |
| 10 | 9, III-2 | 8 | c.214G > A ( | 4 | Hemi | LP (PM2_Supporting + PP3 +PS4) | rs104894928 | Probably_damaging | Tolerable | Disease_causing | Reported | 0.3/0.05 | +/+ | -/+ |
| 11 | 10, II-2 | 10 | c.574C > T ( | 6 | Hemi | LP (PM2_Supporting + PP3+PM1+PS4) | rs61753174 | Probably_damaging | Tolerable | Disease_causing | Reported | 0.3/HM | +/A | +/+ |
OS: left eye. OD: right eye. Hemi: hemizygous. LP: likely pathogenic. P: pathogenic. HM: hand move. FC: finger count. +: present. -: absent. A, atrophy.
FIGURE 2Sequence chromatography of the XLRS families.
FIGURE 3Colored fundus photographs and OCT B scan images of patients 1-6.
FIGURE 4Colored fundus photographs and OCT B scan images of patients 7–11. The fundus images of patient 8 are OCT SLO images.
FIGURE 5OCT and AO fundus image of patients 10 and 11. (A) OCT SLO image of the right eye of patient 10. (B) 6 mm × 6 mm OCT en face image of right macular of patient 10. (C) AO fundus image corresponding to the white dotted box of (A). (D) Enlarged black dotted box in (C). The cones appear as small highlighted dots. (E) OCT SLO image of the right eye of patient 11. (F) AO fundus image corresponding to the white dotted box of (E). (G) Enlarged black dotted box in (F) (scale bar: 100 μm).
FIGURE 6ERG graphs of patients 2, 3, and 9. The first line shows dark-adapted 0.01 ERG. The second line shows dark-adapted 3.0 ERG. The third line shows dark-adapted 10.0 ERG. The fourth line shows light-adapted 3.0 ERG. The abscissa is in milliseconds, and the vertical coordinate is in microvolts.
FIGURE 7ERG graphs of patients 4, 5, 6, 7, and 10. The top-down waves are, respectively, dark-adapted 0.01 ERG, 3.0 ERG, and 10.0 ERG and light-adapted 3.0 ERG.
BCVA and SS-OCT parameters in XLRS patients. P values less than or equal to 0.05 are shown in bold.
| BCVA | Fovea (μm) | ONL (μm) | IS/OS (μm) | |
|---|---|---|---|---|
| Group A | 0.32 ± 0.22 | 332.8 ± 142.5 | 40.2 ± 16.4 | 52.6 ± 14.5 |
| N | 14 | 10 | 10 | 10 |
| Group B | 0.04 ± 0.03 | 343.3 ± 358.9 | 47.2 ± 28.1 | 23.7 ± 14.7 |
| N | 8 | 8 | 7 | 8 |
|
|
| 0.9334 | 0.5242 |
|
FIGURE 8Correlations between BCVA and SS-OCT parameters. (A) BCVA vs. foveal thickness. (B) BCVA vs. ONL thickness. (C) BCVA vs. IS/OS thickness.